{"id":"NCT01796665","sponsor":"Padagis LLC","briefTitle":"A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris","officialTitle":"A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo Israel Pharmaceuticals, Ltd. Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel (Clindamycin Phosphate and Benzoyl Peroxide Gel 1.2%/2.5%), and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-02","primaryCompletion":"2013-02","completion":"2013-02","firstPosted":"2013-02-22","resultsPosted":"2021-01-20","lastUpdate":"2021-10-22"},"enrollment":1180,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acne"],"interventions":[{"type":"DRUG","name":"Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5%","otherNames":["Test product"]},{"type":"DRUG","name":"Acanya Gel","otherNames":["Reference product"]},{"type":"DRUG","name":"Placebo of Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% product","otherNames":["Placebo product"]}],"arms":[{"label":"Test product","type":"EXPERIMENTAL"},{"label":"Reference product","type":"ACTIVE_COMPARATOR"},{"label":"Placebo product","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study was to evaluate the efficacy and safety of Perrigo's test formulation of Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% compared to the already marketed formulation, Acanya gel in patients with acne vulgaris.","primaryOutcome":{"measure":"Mean Percent Change in the Inflammatory (Papules and Pustules) Lesion Count","timeFrame":"Baseline to week 12","effectByArm":[{"arm":"Test Product","deltaMin":61.7,"sd":34.55},{"arm":"Reference Product","deltaMin":63.89,"sd":39.21},{"arm":"Placebo Product","deltaMin":42.22,"sd":43.03}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":474},"commonTop":[]}}